BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives $138.25 Consensus Price Target from Analysts
BioNTech SE Sponsored ADR (NASDAQ:BNTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has given a strong buy recommendation to the company. […]
BioNTech SE Sponsored ADR (NASDAQ:BNTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has given a strong buy recommendation to the company. […]
